{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:21Z","timestamp":1787027061857,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005285","name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Goi\u00e1s","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005675","name":"Funda\u00e7\u00e3o de Desenvolvimento de Tecn\u00f3polis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2018.01073","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T08:51:51Z","timestamp":1533631911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["The Newly Synthesized Pyrazole Derivative 5-(1-(3 Fluorophenyl)-1H-Pyrazol-4-yl)-2H-Tetrazole Reduces Blood Pressure of Spontaneously Hypertensive Rats via NO\/cGMO Pathway"],"prefix":"10.3389","volume":"9","author":[{"given":"Neidiane R.","family":"Trindade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara M.","family":"Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Fajemiroye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia O.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano M.","family":"Li\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C. S.","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdir A.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Menegatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo R.","family":"Pedrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3565(25)22411-9","article-title":"Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension .","volume":"270","author":"Arribas","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/hr.2011.82","article-title":"Vasodilator efficiency of endogenous prostanoids, Ca2+-activated K+ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension.","volume":"34","author":"Behuliak","year":"2011","journal-title":"Hypertens. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial.","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"B20","DOI":"10.1016\/S1520-765X(01)90053-7","article-title":"Principal results from the international nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT).","volume":"3","author":"Brown","year":"2001","journal-title":"Eur. Heart J. Suppl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.ejmech.2008.01.014","article-title":"Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).","volume":"43","author":"Carri\u00f3n","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0163-7258(93)90027-B","article-title":"Muscarinic receptors\u2014characterization, coupling and function.","volume":"58","author":"Caulfield","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.105.063636","article-title":"Kidney in hypertension: guyton redux.","volume":"51","author":"Coffman","year":"2008","journal-title":"Hypertension"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.11606\/issn.2176-7262.v39i1p89-100","article-title":"Os n\u00facleos vasomotores do bulbo e a regula\u00e7\u00e3o cardiovascular: novas evid\u00eancias e novas quest\u00f5es.","volume":"39","author":"Cravo","year":"2006","journal-title":"Medicina"},{"key":"B9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Original papers.","volume":"4","author":"Cushman","year":"2002","journal-title":"J. Clin. Hypertens."},{"key":"B10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.3390\/molecules19079773","article-title":"Vasorelaxation induced by a new naphthoquinone-oxime is mediated by NO-sGC-cGMP pathway.","volume":"19","author":"Dantas","year":"2014","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cbi.2017.09.004","article-title":"In vitro genotoxicity and in vivo subchronic evaluation of the anti-inflammatory pyrazole compound LQFM021.","volume":"277","author":"de Moura","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1749-6632.1999.tb09220.x","article-title":"The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.","volume":"874","author":"Feron","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10787-016-0282-3","article-title":"Pharmacological and toxicological evaluations of the new pyrazole compound (LQFM-021) as potential analgesic and anti-inflammatory agents.","volume":"24","author":"Florentino","year":"2016","journal-title":"Inflammopharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.niox.2015.02.146","article-title":"Involvement of the NO\/cGMP\/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021).","volume":"47","author":"Florentino","year":"2015","journal-title":"Nitric Oxide"},{"key":"B16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.niox.2017.04.006","article-title":"Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: the role of nitric oxide.","volume":"69","author":"Florentino","year":"2017","journal-title":"Nitric Oxide"},{"key":"B17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejphar.2012.06.043","article-title":"The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.","volume":"690","author":"Fran\u00e7a-Silva","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.autneu.2012.10.002","article-title":"The new nitric oxide donor 2-nitrate-1,3-dibuthoxypropan alters autonomic function in spontaneously hypertensive rats.","volume":"171","author":"Fran\u00e7a-Silva","year":"","journal-title":"Auton. Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bmcl.2013.01.028","article-title":"Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators.","volume":"23","author":"Griebenow","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ejmech.2014.07.057","article-title":"New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.","volume":"84","author":"Grosse","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0223-5234(00)00117-3","article-title":"Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents.","volume":"35","author":"G\u00fcrsoy","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.","volume":"359","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the swedish trial in old patients with Hypertension-2 study.","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial.","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"B25","first-page":"1","article-title":"Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat.","volume":"26","author":"Head","year":"1989","journal-title":"Blood Vessels"},{"key":"B26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ejmech.2014.11.059","article-title":"Recent advances in bioactive pyrazoles.","volume":"97","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.3390\/molecules19068140","article-title":"Synthesis and fungicidal activity of novel chloro-containing 1-Aryl-3-oxypyrazoles with an oximino ester or oximino amide moiety.","volume":"19","author":"Liu","year":"2014","journal-title":"Molecules"},{"key":"B29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1590\/1809-9823.2015.14056","article-title":"Prescri\u00e7\u00e3o inadequada de medicamentos a idosos portadores de doen\u00e7as cr\u00f4nicas em um plano de sa\u00fade no munic\u00edpio de S\u00e3o Paulo, Brasil.","volume":"18","author":"Manso","year":"2015","journal-title":"Rev. Bras. Geriatr. Gerontol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2014.03.039","article-title":"Differential modulation of GABAA receptor function by aryl pyrazoles.","volume":"733","author":"Mascia","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men \u2013 A comparison of six antihypertensive agents with placebo.","volume":"328","author":"Materson","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/00004872-199312050-00007","article-title":"Critical assessment of international clinical development programmes for new antihypertensive drugs.","volume":"11","author":"M\u00e9nard","year":"1993","journal-title":"J. Hypertens. Suppl."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00243","article-title":"The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO\/cGMP\/PKG pathway.","volume":"6","author":"Mendes-J\u00fanior","year":"2015","journal-title":"Front. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1248\/cpb.c12-01016","article-title":"Synthesis, docking studies, pharmacological activity and toxicity of a novel pyrazole derivative (LQFM 021)\u2013possible effects on phosphodiesterase.","volume":"61","author":"Ramos Martins","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"B35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.abb.2014.11.003","article-title":"CRLI induces vascular smooth muscle relaxation and suggests a dual mechanism of eNOS activation by legume lectins via muscarinic receptors and shear stress.","volume":"565","author":"Rocha","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1021\/bi801989c","article-title":"The G\u03b2 5 -RGS7 complex selectively inhibits muscarinic M3 receptor signaling via the interaction between the third intracellular loop of the receptor and the DEP Domain of RGS7 \u2020.","volume":"48","author":"Sandiford","year":"2009","journal-title":"Biochemistry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/0929867321666141106113018","article-title":"New antihypertensive drugs under development.","volume":"22","author":"Tamargo","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).","volume":"288","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1113\/expphysiol.2009.047399","article-title":"Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension?","volume":"95","author":"Toney","year":"2010","journal-title":"Exp. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1440-1681.1991.tb01478.x","article-title":"Presynaptic regulation of neurotransmitter release in hypertension.","volume":"18","author":"Tsuda","year":"1991","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00877757","article-title":"Muscarinic receptors and drugs in cardiovascular medicine.","volume":"9","author":"van Zwieten","year":"1995","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1590\/S0101-60832010000200007","article-title":"Colinergic system: revisiting receptors, regulation and the relationship with Alzheimer disease, schizophrenia, epilepsy and smoking.","volume":"37","author":"Ventura","year":"2010","journal-title":"Arch. Clin. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting\u2013enzyme inhibitors and diuretics for hypertension in the elderly.","volume":"348","author":"Wing","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.bmcl.2014.03.063","article-title":"Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.","volume":"24","author":"Winters","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1734-1140(13)71085-5","article-title":"Marsanidine and 7-Me-marsanidine, the new hypotensive imidazolines augment sodium and urine excretion in rats.","volume":"65","author":"Wr\u00f3blewska","year":"2013","journal-title":"Pharmacol. Rep."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T03:13:30Z","timestamp":1751771610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":45,"alternative-id":["10.3389\/fphys.2018.01073"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2018.01073","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"article-number":"1073"}}